Qiagen NV (QGEN) PT Raised to $43 at BofA/Merrill Lynch

Go back to Qiagen NV (QGEN) PT Raised to $43 at BofA/Merrill Lynch

Qiagen NV (QGEN) PT Raised to $45 at Barclays

June 21, 2019 3:47 AM EDT

Barclays raised its price target on Qiagen NV (NYSE: QGEN) to $45.00 (from $43.00) while maintaining a Overweight rating.

... More